Funding agencies: Michael J Fox Foundation; Mayo Clinic Morris K. Udall Parkinson's Disease Research Center of Excellence (NINDS P50NS072187); South African Medical Research Council.
Letters: New Observations
Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients
Version of Record online: 6 SEP 2013
© 2013 Movement Disorder Society
Volume 28, Issue 14, pages 2039–2040, December 2013
How to Cite
Bardien, S., Blanckenberg, J., van der Merwe, L., Farrer, M. J. and Ross, O. A. (2013), Patient-control association study of the Leucine-Rich repeat kinase 2 (LRRK2) gene in South African Parkinson's disease patients. Mov. Disord., 28: 2039–2040. doi: 10.1002/mds.25637
Relevant conflicts of interest/financial disclosures: Nothing to report.
Full financial disclosures and author roles may be found in the online version of this article.
- Issue online: 9 DEC 2013
- Version of Record online: 6 SEP 2013
- Manuscript Accepted: 6 JUN 2013
- Manuscript Revised: 14 MAY 2013
- Manuscript Received: 12 MAR 2013
Additional Supporting Information may be found in the online version of this article.
|mds25637-sup-0001-suppfig1.doc||106K||Supplementary Information Figure 1|
|mds25637-sup-0002-supptab1.doc||40K||Supplementary Information Table 1|
|mds25637-sup-0003-supptab2.doc||107K||Supplementary Information Table 2|
|mds25637-sup-0004-supptab3.doc||58K||Supplementary Information Table 3|
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.